AegirBio AB's market cap is currently €2.19M. The company's EPS TTM is €; its P/E ratio is ―; AegirBio AB is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
